Moleculin Biotech, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Moleculin Biotech, Inc. (MBRX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $21.00 thousand as of 2018-06-30, per its 10-Q filed 2018-08-10.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-08-10
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $21.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $34.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-06-30 | $21.00K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $34.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |